272 related articles for article (PubMed ID: 33108403)
1. The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients.
Liu L; Wang R; Ding H; Tian L; Gao T; Bao C
PLoS One; 2020; 15(10):e0240942. PubMed ID: 33108403
[TBL] [Abstract][Full Text] [Related]
2. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare.
Go DJ; Lee JY; Kang MJ; Lee EY; Lee EB; Yi EC; Song YW
Lupus; 2018 Sep; 27(10):1600-1615. PubMed ID: 29958502
[TBL] [Abstract][Full Text] [Related]
3. Urinary neutrophil gelatinase-associated lipocalin (uNGAL) and kidney injury molecule-1 (uKIM-1) as markers of active lupus nephritis.
Ibrahim WHM; Sabry AA; Abdelmoneim AR; Marzouk HFA; AbdelFattah RM
Clin Rheumatol; 2024 Jan; 43(1):167-174. PubMed ID: 37516706
[TBL] [Abstract][Full Text] [Related]
4. The role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis.
Alharazy SM; Kong NC; Mohd M; Shah SA; Abdul Gafor AH; Ba'in A
Clin Chim Acta; 2013 Oct; 425():163-8. PubMed ID: 23954775
[TBL] [Abstract][Full Text] [Related]
5. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
[TBL] [Abstract][Full Text] [Related]
6. The Role of urinary kidney injury molecule 1 (KIM-1) in monitoring the treatment response in Egyptian Lupus Nephritis Patients.
Khedr L; El-Shinnawy H; Hebah H; Rashwan H; Elsharabasy RM
Egypt J Immunol; 2024 Jan; 31(1):124-132. PubMed ID: 38224469
[TBL] [Abstract][Full Text] [Related]
7. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
8. Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis.
Ding H; Shen Y; Lin C; Qin L; He S; Dai M; Okitsu SL; DeMartino JA; Guo Q; Shen N
Arthritis Res Ther; 2022 Mar; 24(1):77. PubMed ID: 35346341
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity.
Gupta R; Yadav A; Aggarwal A
Clin Rheumatol; 2016 Nov; 35(11):2707-2714. PubMed ID: 27624649
[TBL] [Abstract][Full Text] [Related]
10. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
[TBL] [Abstract][Full Text] [Related]
11. Urinary Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (uTWEAK) and Urinary Monocyte Chemo-attractant Protein-1 (uMCP-1): Promising Biomarkers of Lupus Nephritis Activity?
Elsaid DS; Abdel Noor RA; Shalaby KA; Haroun RA
Saudi J Kidney Dis Transpl; 2021; 32(1):19-29. PubMed ID: 34145111
[TBL] [Abstract][Full Text] [Related]
12. Urinary activated leukocyte cell adhesion molecule as a novel biomarker of lupus nephritis histology.
Ding H; Lin C; Cai J; Guo Q; Dai M; Mohan C; Shen N
Arthritis Res Ther; 2020 May; 22(1):122. PubMed ID: 32460901
[TBL] [Abstract][Full Text] [Related]
13. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
Front Immunol; 2022; 13():885307. PubMed ID: 35720325
[TBL] [Abstract][Full Text] [Related]
14. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
[TBL] [Abstract][Full Text] [Related]
15. Combined detection of uMCP-1 and uTWEAK for rapid discrimination of severe lupus nephritis.
Dong XW; Zheng ZH; Ding J; Luo X; Li ZQ; Li Y; Rong MY; Fu YL; Shi JH; Yu LC; Wu ZB; Zhu P
Lupus; 2018 May; 27(6):971-981. PubMed ID: 29451067
[TBL] [Abstract][Full Text] [Related]
16. Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis.
Satirapoj B; Kitiyakara C; Leelahavanichkul A; Avihingsanon Y; Supasyndh O
BMC Nephrol; 2017 Aug; 18(1):263. PubMed ID: 28778196
[TBL] [Abstract][Full Text] [Related]
17. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages.
Zhang T; Li H; Vanarsa K; Gidley G; Mok CC; Petri M; Saxena R; Mohan C
Front Immunol; 2020; 11():671. PubMed ID: 32351512
[TBL] [Abstract][Full Text] [Related]
18. Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.
Amer AS; Abdel Moneam SM; Hashaad NI; Yousef EM; Abd El-Hassib DM
Clin Rheumatol; 2024 Mar; 43(3):1015-1021. PubMed ID: 38294724
[TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of a Urinary Biomarker Panel to Accurately Diagnose and Predict Response to Therapy in Lupus Nephritis.
Whittall-Garcia L; Goliad K; Kim M; Bonilla D; Gladman D; Urowitz M; Fortin PR; Atenafu EG; Touma Z; Wither J
Front Immunol; 2022; 13():889931. PubMed ID: 35711439
[TBL] [Abstract][Full Text] [Related]
20. International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
Smith EM; Jorgensen AL; Midgley A; Oni L; Goilav B; Putterman C; Wahezi D; Rubinstein T; Ekdawy D; Corkhill R; Jones CA; Marks SD; Newland P; Pilkington C; Tullus K; Beresford MW
Pediatr Nephrol; 2017 Feb; 32(2):283-295. PubMed ID: 27590021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
